Nerves and neovessels inhibit each other in the cornea

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 813-820

  Ferrari, Giulio ^a,b   Hajrasouliha, Amir R ^a   Sadrai, Zahra ^a   Ueno, Hiroki ^a   Chauhan, Sunil K ^a   Dana, Reza ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN ZINC PLUS NEOMYCIN PLUS POLYMYXIN B; BETA TUBULIN; BUPRENORPHINE; CD11B ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; PIGMENT EPITHELIUM DERIVED FACTOR; TETRACYCLINE; VASCULOTROPIN RECEPTOR 3;

ABLATION THERAPY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; DENERVATION; ELECTROLYSIS; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MALE; MOUSE; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD45; CORNEA; CORNEAL NEOVASCULARIZATION; DENERVATION; DISEASE MODELS, ANIMAL; ELECTROLYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NERVE DEGENERATION; NERVE GROWTH FACTORS; OPHTHALMIC ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; SIGNAL TRANSDUCTION; TRIGEMINAL NERVE; TUBULIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84874720799     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8379     Document Type: Article

References (49)

1. Tessier-Lavigne M, Goodman CS. The molecular biology of axon guidance. Science. 1996;274:1123-1133.
2. Dickson BJ. Molecular mechanisms of axon guidance. Science. 2002;298:1959-1964.
3. Huber AB, Kolodkin AL, Ginty DD, Cloutier, JF. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Annu Rev Neurosci. 2003;26:509-563.
4. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161:1163-1177.
5. Carmeliet P, Smet FD, Loges S, Mazzone M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Na. Rev Clin Oncol. 2009;6:315-326.
6. Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci. 2002;43:3500-3510.
7. Suchting S, Bicknell R, Eichmann A. Neuronal clues to vascular guidance. Exp Cell Res. 2006;312:668-675.
8. Larrivée B, Freitas C, Suchting S, Brunet I, Eichmann A. Guidance of vascular development: lessons from the nervous system. Circ Res. 2009;104:428-441.
9. Jones CA, Li DY. Common cues regulate neural and vascular patterning. Curr Opin Genet Dev. 2007;17:332-336.
10. Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 2007;16:285-299.
11. Torres-Vázquez J, Gitler AD, Fraser SD, et al. Semaphorinplexin signaling guides patterning of the developing vasculature. Dev Cell. 2004;7:117-123.
12. Friedman A, Kaufer D, Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 2009;85:142-149.
13. Ndode-Ekane XE, Hayward N, Gröhn O, Pitk̈anen A. Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience. 2010;166:312-332.
14. Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol. 2011;2011:765923.
15. Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003;17:989-995.
16. Sellami D, Abid S, Bouaouaja G, Ben Amor S, Kammoun B, Masmoudi M, et al. Epidemiology and risk factors for corneal graft rejection. Transplant Proc. 2007;38:2609-2611.
17. Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A. 1994;91: 12096-12100.
18. Sunderkötter C, Roth J, Sorg C. Immunohistochemical detection of bFGF and TNF-alpha in the course of inflammatory angiogenesis in the mouse cornea. Am J Pathol. 1990; 137:511-515.
19. Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol. 2001;158:1111-1120.
20. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in woundand inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
21. Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C, Javaherian K, et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol. 2002;120:1063-1068.
22. Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264-302.
23. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A. 2006;103:11405-11410.
24. Abdiu O, Van Setten G. Antiangiogenic activity in tears: presence of pigment-epithelium-derived factor. New insights and preliminary results. Ophthalmic Res. 2008;40:16-18.
25. Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, et al. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004;45: 1117-1124.
26. Ashton N. Cornea vascularization. In: Duke-Elder S, Perkins ES, eds. The Transparency of the Cornea. A Symposium. Oxford, UK: Blackwell Scientific Publications; 1960:131-147.
27. Lim P, Fuchsluger TA, Jurkunas UV. Limbal stem cell deficiency and corneal neovascularization. Semin Ophthalmol. 2009;24: 139-148.
28. Epstein DL, Paton D. Keratitis from misuse of corneal anesthetics. N Engl J Med. 1968;279:396-399.
29. Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthal Vis Sci. 2004;45:3030-3035.
30. Chung ES, Saban DR, Chauhan SK, Dana R. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009;50:1613-1618.
31. Ferrari G, Chauhan SK, Ueno H, Nallasamy N, Gandolfi S, Borges L, et al. A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. Invest Ophthalmol Vis Sci. 2011;52:2532-2539.
32. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000; 41:2514-2522.
33. Singh N, Amin S, Richter E, Rashid S, Scoglietti V, Jani PD, et al. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci. 2005;46:1647-1652.
34. Huang AJ, Tseng SC. Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci. 1991;32:96-105.
35. Tseng SC. Concept and application of limbal stem cells. Eye (Lond). 1989;3:141-157.
36. Lazarovici P, Gazit A, Staniszewska I, Marcinkiewicz C, Lelkes PI. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane. Endothelium. 2006;13:51-59.
37. Meyer C, Notari L, Becerra SP. Mapping the type I collagenbinding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem. 2002;277: 45400-45407.
38. Edén U, Riise R, Tornqvist K. Corneal involvement in congenital aniridia. Cornea. 2010;29:1096-1102.
39. Leiper LJ, Ou J, Walczysko P. Control of patterns of corneal innervation by Pax6. Invest Ophthalmol Vis Sci. 2009;50: 1122-1128.
40. Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S. Ocular surface abnormalities in aniridia. Am J Ophthalmol. 1995;120:368-375.
41. Alzheimer C, Werner S. Fibroblast growth factors and neuroprotection. Adv Exp Med Biol. 2002;513:335-351.
42. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J. 2009;276:13-26.
43. Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of FGF-2, to increase motor neuron survival. Exp Neurol. 2002;173:46-62.
44. Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004;78:151-156.
45. Steinle JJ, Pierce JD, Clancy RL, Smith P. Increased ocular blood vessel numbers and sizes following chronic sympathectomy in rat. Exp Eye Res. 2002;74:761-768.
46. Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta PS, et al. Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res. 2004;64:5551-5555.
47. David Dong ZM, Aplin AC, Nicosia RF. Regulation of angiogenesis by macrophages, dendritic cells, and circulating myelomonocytic cells. Curr Pharm Des. 2009;15:365-379.
48. Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N, et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009;175:1984-1992.
49. Karakousis PC, John SK, Behling KC, Surace EM, Smith JE, Hendrickson A, et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis. 2001;7:154-163.